| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.7 | 0.2 | 0.0 |
| Other income | 0.2 | 0.0 | 0.0 |
| Total income | 0.9 | 0.2 | 0.0 |
| Profit before exceptional items & tax | 0.8 | -0.1 | -0.1 |
| Profit before tax | 0.8 | -0.1 | -0.1 |
| Net profit | 0.7 | -0.1 | -0.1 |
| Operating margin | 88.9% | -50.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Operating profit, year on year | +700.00% |
|---|---|
| Operating profit, quarter on quarter | +700.00% |
BSE results filing, NSE: SRDAPRT. Figures extracted from the filing.
Sarda Proteins Ltd: key numbers
- Share price
- ₹158.03
- Market cap
- ₹141.8 Cr
- Revenue (annual)
- ₹16.16 Cr
- Net profit (annual)
- ₹0.64 Cr
- P/E (TTM)
- 50.8×Sector 43.4×
- Promoter holding
- 80.66%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sarda Proteins Ltd
All →Sarda Proteins Price Movement Clarification
Sarda Proteins Limited responded to a BSE query regarding recent stock price movement. The company stated the fluctuations are driven by market forces and conditions.
Sarda Proteins Other Announcement
Sarda Proteins Limited has changed its name to Fresita Proteins Limited, effective September 21, 2026. The name change received approval from the Ministry of Corporate Affairs and BSE.
Sarda Proteins Annual Report
Sarda Proteins Limited filed its 35th Annual Report for the financial year ended 31st March 2026 with the stock exchange.
Sarda Proteins Annual General Meeting
Sarda Proteins set its 35th AGM for September 30, 2026, with book closure September 24–30. E-voting cut-off date is September 23, 2026.
Sarda Proteins Board Meeting Outcome
Sarda Proteins board approved convening its AGM on September 30, 2026, along with e-voting, scrutinizer, and register-closure arrangements. No financial or operational decisions were taken.
Sarda Proteins Q1 FY27 Results: Turns Profitable, Net Profit ₹1.7 Cr
Sarda Proteins Ltd reported revenue from operations of ₹13 Cr (+18.2% YoY) and net profit of ₹1.7 Cr for Q1 FY27.
- Key figure
- Net profit ₹1.7 Cr